172 related articles for article (PubMed ID: 34220962)
1. Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism.
Liu B; Zhang Y; Suo J
Front Genet; 2021; 12():689585. PubMed ID: 34220962
[TBL] [Abstract][Full Text] [Related]
2. PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer.
Zhang Z; Han S; Ouyang S; Zeng Z; Liu Z; Sun J; Kang W
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626257
[TBL] [Abstract][Full Text] [Related]
3. Tumor Endothelial Marker TEM7 is a Prognostic Biomarker and Correlating with Immune Infiltrates in Gastric Cancer.
Geng L; Chen S; Gong Y; Zhou Y; Yang H; Tang L
Int J Gen Med; 2021; 14():10155-10171. PubMed ID: 34992436
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
Cheng A; Guo X; Dai X; Wang Z
FEBS Open Bio; 2021 Jun; 11(6):1785-1798. PubMed ID: 33837660
[TBL] [Abstract][Full Text] [Related]
5. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
Fang W; Wan D; Yu Y; Zhang L
Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
[TBL] [Abstract][Full Text] [Related]
6. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
7. NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells.
Ren S; Chen M; Chen Y; Ding K
Protein Pept Lett; 2023; 30(5):427-438. PubMed ID: 36918782
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of TOP1MT enhances glycolysis through the stimulation of PDK4 expression in gastric cancer.
Wang H; Sun X; Yang C; Li Z; Jin D; Zhu W; Yu Z
Cancer Metab; 2024 Jan; 12(1):2. PubMed ID: 38200513
[TBL] [Abstract][Full Text] [Related]
9. MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer.
Miao Y; Li Q; Sun G; Wang L; Zhang D; Xu H; Xu Z
Cancer Med; 2020 Oct; 9(19):7231-7243. PubMed ID: 32780563
[TBL] [Abstract][Full Text] [Related]
10. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
11. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
Zhao H; Jiang R; Feng Z; Wang X; Zhang C
J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
[TBL] [Abstract][Full Text] [Related]
12. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the prognostic value and immune infiltration of
Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
Front Oncol; 2022; 12():936952. PubMed ID: 36147913
[TBL] [Abstract][Full Text] [Related]
14. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
15. Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axis.
Li M; Cai O; Yu Y; Tan S
Phytomedicine; 2022 Feb; 96():153903. PubMed ID: 35026514
[TBL] [Abstract][Full Text] [Related]
16. Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion
Zhang C; Ma MH; Liang Y; Wu KZ; Dai DQ
World J Gastrointest Oncol; 2019 Feb; 11(2):91-101. PubMed ID: 30788037
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic role of PDK4 in human colon cancer cells.
Leclerc D; Pham DN; Lévesque N; Truongcao M; Foulkes WD; Sapienza C; Rozen R
Br J Cancer; 2017 Mar; 116(7):930-936. PubMed ID: 28208156
[TBL] [Abstract][Full Text] [Related]
18. Low KCNQ1 expression is associated with unfavorable outcome and metabolism of gastric cancer.
Yang Z; Duan S; Hu X; Dai B; Bao G; Xin W
Am J Transl Res; 2023; 15(6):3992-4005. PubMed ID: 37434821
[TBL] [Abstract][Full Text] [Related]
19. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
20. Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer.
Wang J; Qian Y; Gao M
Cancer Manag Res; 2019; 11():251-262. PubMed ID: 30636897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
